Updated fields: d9, g3, g6, h2, h3, h6, h10.Additional information - the facility has advised that the indication for use of duraseal was an endoscopic transphenoidal pituitary adenoma procedure.Failure analysis - duraseal sealant (202050) was not returned for evaluation; therefore, an evaluation of the device could not be performed.Additionally, the lot number provided by the customer (n0g07166y) does not belong to a valid production lot number; the closest lot number identified in our records is n0g0166y manufactured in august 2020.A dhr review and trending was performed on closest lot number n0g0166y as part of the evaluation.Proper finished good testing is performed prior to release as indicated on the product dhrs.Root cause analysis - the investigation could not confirm the complaint reported condition, and the root cause is undetermined since the product was not received for analysis,.Per the dfmea, potential causes of failure include: performance, adhesion barrier.The risk remains acceptable per the risk analysis.If additional relevant information becomes available in the future, this complaint will be reopened, and the respective evaluation performed.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
|
Duraseal dural sealant system 5ml box of 5 (202050) was returned for evaluation: device history record (dhr): dhr review was performed and determined there were no anomalies found in association to the complaint incident.Failure analysis: evaluation was unable to conclusively verify customer information as valid.The visual inspection of the returned product noted that the caps were fully depressed, the blue pre-cursor was fully applied, and the clear syringe was fully applied.There was some liquid in the powder vial.The reported complaint is unconfirmed.Root cause analysis: the root cause is undetermined and was unable to be confirmed in the complaint evaluation.A dhr review and trending were performed as part of the evaluation.Proper finished good testing was performed prior to release as indicated in the dhr.Product was received for analysis and the investigation could not confirm the complaint.Trends will be monitored for this and similar issues.At present, we consider this complaint to be closed.
|